Gene · 3597
Papers1,963
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 1,963
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Potential Importance of MicroRNAs as Novel Indicators How to Manage Patients with Juvenile Idiopathic Arthritis More Effectively. | J Immunol Res | 2021 | 33575364 | PubTator, text mining | PubMed |
| Definitive Radiotherapy in the Management of Non-Resectable or Residual Retroperitoneal Sarcomas: Institutional Cohort Analysis and Systematic Review. | Cancer Control | 2021 | 33567904 | PubTator, text mining | PubMed |
| Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders. | Int J Mol Sci | 2021 | 33562713 | PubTator, text mining | PubMed |
| A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma. | Biomed Res Int | 2021 | 33553434 | PubTator, text mining | PubMed |
| Ruxolitinib inhibits poly(I:C) and type 2 cytokines-induced CCL5 production in bronchial epithelial cells: A potential therapeutic agent for severe eosinophilic asthma. | Immun Inflamm Dis | 2021 | 33534941 | PubTator, text mining | PubMed |
| A Comprehensive Analysis Identified Hub Genes and Associated Drugs in Alzheimer's Disease. | Biomed Res Int | 2021 | 33506048 | PubTator, text mining | PubMed |
| MicroRNA-155: Regulation of Immune Cells in Sepsis. | Mediators Inflamm | 2021 | 33505221 | PubTator, text mining | PubMed |
| Escape from X Chromosome Inactivation and the Female Predominance in Autoimmune Diseases. | Int J Mol Sci | 2021 | 33498655 | PubTator, text mining | PubMed |
| The Match between Molecular Subtypes, Histology and Microenvironment of Pancreatic Cancer and Its Relevance for Chemoresistance. | Cancers (Basel) | 2021 | 33477288 | PubTator, text mining | PubMed |
| Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer. | Int J Mol Sci | 2021 | 33450900 | PubTator, text mining | PubMed |
| Sex differences in M2 polarization, chemokine and IL-4 receptors in monocytes and macrophages from asthmatics. | Cell Immunol | 2021 | 33450610 | PubTator, text mining | PubMed |
Effects of Unsweetened Preloads and Preloads Sweetened with Caloric or Low-/No-Calorie Sweeteners on Subsequent Energy Intakes: A Systematic Review and Meta-Analysis of Controlled Human Intervention Studies. | Adv Nutr | 2021 | 33439973 | PubTator, text mining | PubMed |
| Expression of IL4Rα and IL13Rα1 are associated with poor prognosis of soft-tissue sarcoma of the extremities, superficial trunk, and retroperitoneum. | Diagn Pathol | 2021 | 33419470 | PubTator, text mining | PubMed |
| Rational Design of Molecularly Imprinted Polymers Using Quaternary Ammonium Cations for Glyphosate Detection. | Sensors (Basel) | 2021 | 33406759 | PubTator, text mining | PubMed |
| Roles of miRNA dysregulation in the pathogenesis of multiple myeloma. | Cancer Gene Ther | 2021 | 33402729 | PubTator, text mining | PubMed |
| Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis. | Int J Mol Sci | 2021 | 33401724 | PubTator, text mining | PubMed |
| A review on the effect of COVID-19 in type 2 asthma and its management. | Int Immunopharmacol | 2021 | 33385710 | PubTator, text mining | PubMed |
| Mast cell-derived IL-13 downregulates IL-12 production by skin dendritic cells to inhibit the TH1 cell response to cutaneous antigen exposure. | J Allergy Clin Immunol | 2021 | 33316284 | PubTator, text mining | PubMed |
| CYT387, a Novel JAK2 Inhibitor, Suppresses IL-13-Induced Epidermal Barrier Dysfunction Via miR-143 Targeting IL-13Rα1 and STAT3. | Biochem Genet | 2021 | 33190168 | PubTator, text mining | PubMed |
| miR-31 attenuates murine allergic rhinitis by suppressing interleukin-13-induced nasal epithelial inflammatory responses. | Mol Med Rep | 2021 | 33179116 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3597/papers?page=38